Five drugs, including Trelegy Ellipta, a treatment for COPD are scheduled to be registered for insurance in accordance with next month's schedule, and salary standards will be established and changed accordingly.

The MOHW has partially amended its notice of 'details on the criteria and methods of applying care benefits' to ensure proper insurance coverage of the drug and has entered into an inquiry.

The drugs that will be applied to the revision include Trelegy Ellipta, Rosuvaco Soft Cap, Rosumega Soft Cap, and Pentosin 350mg and Ultomiris, which will be registered on June 1st. Among them, the drugs listed as of June 7 are likely to be partially changed following the Health Insurance Pol